 |
 |
The Mid Yorkshire Hospitals
NHS Trust |
| Formulary Chapter 5: Infections - Full Section
|
| Useful Links |
 NICE NG15: Antimicrobial Stewardship: systems and processes for effective antimicrobial medicine use |
|
NICE NG63: Antimicrobial Stewardship: changing risk-related behaviours in the general population |
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
05.01 |
Antibacterial drugs
(0,0)
|
|
|
Table 1. Summary of antibacterial therapy
(0,0)
|
|
|
Table 2. Summary of antibacterial prophylaxis
(0,0)
|
|
05.01.01 |
Penicillins
(0,0)
|
|
05.01.01.01 |
Benzylpenicillin and phenoxymethylpenicillin
(4,0)
|
|
05.01.01.02 |
Penicillinase-resistant penicillins
(2,0)
|
|
05.01.01.03 |
Broad-spectrum penicillins
(2,2)
|
|
05.01.01.04 |
Antipseudomonal penicillins
(1,1)
|
|
05.01.01.05 |
Mecillinams
(1,0)
|
|
05.01.02 |
Cephalosporins, carbapenems and other beta-lactums
(0,0)
|
|
05.01.02.01 |
Cephalosporins
(10,4)
|
|
05.01.02.02 |
Carbapenems
(2,1)
|
|
05.01.02.03 |
Other beta-lactums antibiotics
(1,2)
|
|
05.01.03 |
Tetracyclines
(4,1)
|
|
|
Tigecycline
(1,0)
|
|
05.01.04 |
Aminoglycosides
(4,1)
|
|
05.01.05 |
Macrolides
(3,1)
|
|
05.01.06 |
Clindamycin
(1,0)
|
|
05.01.07 |
Some other antibacterials
(3,0)
|
|
|
Chloramphenicol
(1,0)
|
|
|
Fusidic acid
(1,0)
|
|
|
Vancomycin, teicoplanin and dalbavancin
(3,0)
|
|
|
Daptomycin
(1,0)
|
|
|
Linezolid
(1,0)
|
|
|
Quinupristin and dalfopristin
(0,0)
|
|
|
Polymyxins
(1,0)
|
|
05.01.08 |
Sulphonamides and trimethoprim
(2,3)
|
|
05.01.09 |
Antituberculosis drugs
(8,4)
|
|
05.01.10 |
Antileprotic drugs
(1,1)
|
|
05.01.11 |
Metronidazole and tinidazole
(1,1)
|
|
05.01.12 |
Quinolones
(3,3)
|
|
05.01.13 |
Urinary-tract infections
(2,1)
|
|
05.02 |
Antifungal drugs
(0,0)
|
|
|
Treatment of fungal infections
(0,0)
|
|
05.02.01 |
Triazole antifungals
(3,1)
|
|
05.02.02 |
Imidazole antifungals
(0,1)
|
|
05.02.03 |
Polyene antifungals
(1,0)
|
|
05.02.04 |
Echinocandin antifungals
(2,1)
|
|
05.02.05 |
Other antifungals
(2,1)
|
|
05.03 |
Antiviral drugs
(1,0)
|
|
05.03.01 |
HIV infection
(0,0)
|
|
|
Nucleoside reverse transcriptase inhibitors
(14,2)
|
|
|
Protease inhibitors
(6,5)
|
|
|
Non-nucleoside reverse transcriptase inhibitors
(3,0)
|
|
|
Other antiretrovirals
(5,1)
|
|
05.03.02 |
Herpesvirus infections
(0,0)
|
|
05.03.02.01 |
Herpes simplex and varicella-zoster infection
(3,1)
|
|
05.03.02.02 |
Cytomegalovirus infrection
(2,2)
|
|
05.03.03 |
Viral hepatitis
(0,4)
|
|
05.03.03.01 |
Chronic hepatitis B
(0,0)
|
|
05.03.03.02 |
Chronic hepatitis C
(0,0)
|
|
05.03.04 |
Influenza
(3,0)
|
|
05.03.05 |
Respiratory syncytial virus
(1,1)
|
|
05.04 |
Antiprotozoal drugs
(0,1)
|
|
05.04.01 |
Antimalarials
(0,0)
|
|
|
Treatment of malaria
(0,0)
|
|
|
Falciparum malaria (treatment)
(0,0)
|
|
|
Benign malarias (treatment)
(0,0)
|
|
|
Prophylaxis against malaria
(0,0)
|
|
|
Specific recommendations
(0,0)
|
|
|
Artemether with lumefabtrine
(1,0)
|
|
|
Chloroquine
(1,0)
|
|
|
Mefloquine
(0,1)
|
|
|
Primaquine
(1,0)
|
|
|
Proguanil
(1,1)
|
|
|
Pyrimethamine
(1,2)
|
|
|
Quinine
(2,0)
|
|
|
Tetracyclines
(1,0)
|
|
05.04.02 |
Amoebicides
(2,1)
|
|
05.04.03 |
Trichomonacides
(1,0)
|
|
05.04.04 |
Antigiardial drugs
(2,0)
|
|
05.04.05 |
Leishmaniacides
(1,0)
|
|
05.04.06 |
Trypanocides
(0,0)
|
|
05.04.07 |
Drugs for toxoplasmosis
(0,0)
|
|
05.04.08 |
Drugs for pneumocystis pneumonia
(2,1)
|
|
05.05 |
Anthelmintics
(0,0)
|
|
05.05.01 |
Drugs for threadworms
(2,2)
|
|
05.05.02 |
Ascaricides
(0,0)
|
|
05.05.03 |
Drugs for tapeworm infections
(0,1)
|
|
|
Taenicides
(0,0)
|
|
|
Hydatid disease
(0,0)
|
|
05.05.04 |
Drugs for hookworms
(0,0)
|
|
05.05.05 |
Schistosomicides
(0,1)
|
|
05.05.06 |
Filaricides
(0,0)
|
|
05.05.07 |
Drugs for cutaneous larva migrans
(0,1)
|
|
05.05.08 |
Drugs for strongyloidiasis
(0,0)
|
|
|
|
